1-3 of 3
Carly Selan
Close
Sort by
Journal Articles

Endothelial-Targeted CD39 Ameliorates Pulmonary Hypertension in a Murine Model of Endothelial Toxin Administration

Abbey Willcox, Xiaowei Wang, Carly Selan, Natsha Lee, Ilaria Calvello, Viktoria Bongcaron, Aidan Walsh, Yuyang Song, Simon C. Robson, Karlheinz Peter, Maithili Sashindranath, Harshal Nandurkar
Journal: Blood
Blood (2022) 140 (Supplement 1): 1658–1659.
https://doi.org/10.1182/blood-2022-159298
Published: 2022
Journal Articles

CD39 and CD73 Activity Are Protective in a Mouse Model of Antiphospholipid Antibody-Induced Miscarriage

Harshal Nandurkar, MDPhD, Anushka Samudra, MSc, Karen Dwyer, MBBS, PhD FRACP, Carly Selan, BSc, Sussana Freddi, Mandana Nikpour, Michael Hickey, Karlheinz Peter, Simon Robson, Maithili Sashindranath, Peter Cowan
Journal: Blood
Blood (2017) 130 (Supplement 1): 459.
https://doi.org/10.1182/blood.V130.Suppl_1.459.459
Published: 2017
Journal Articles

Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Jan David Hohmann, Xiaowei Wang, Stefanie Krajewski, Carly Selan, Carolyn A. Haller, Andreas Straub, Elliot L. Chaikof, Harshal H. Nandurkar, Christoph E. Hagemeyer, Karlheinz Peter
Journal: Blood
Blood (2013) 121 (16): 3067–3075.
https://doi.org/10.1182/blood-2012-08-449694
Published: 2013
Includes: Supplemental data